Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-09-26 Purchase |
2024-09-30 4:53 pm |
Outlook Therapeutics Inc. | OTLK | KENYON LAWRENCE A Chief Financial Officer |
5,000 | $5.6892 | $28,446 | 5,946 (Direct) |
View |
| 2024-04-15 Purchase |
2024-04-17 8:21 pm |
Outlook Therapeutics Inc. | OTLK | Syntone Ventures LLC 10% Owner |
714,286 | $0 | $0 | 2,776,867 (Direct) |
View |
| 2024-03-28 Purchase |
2024-03-29 10:39 am |
Outlook Therapeutics Inc. | OTLK | Haddadin Yezan Munther Director |
1,882 | $11.82 | $22,242 | 5,049 (Direct) |
View |
| 2024-03-07 Purchase |
2024-03-11 4:43 pm |
Outlook Therapeutics Inc. | OTLK | Evanson Jeff CHIEF COMMERCIAL OFFICER |
62,484 | $0.42 | $26,243 | 808,459 (Direct) |
View |
| 2023-04-20 Sale |
2023-04-21 9:05 pm |
Outlook Therapeutics Inc. | OTLK | Dagnon Terry Chief Operations Officer |
520,000 | $1.135 | $590,200 | 653,058 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-17 Exercise(A) |
2025-03-12 8:56 pm |
N/A N/A |
Outlook Therapeutics Inc. | OTLK | Sukhtian Ghiath M. GMS Ventures & Investments Director 10% Owner |
3,458,571 | $2.51 | 9,266,645 (Indirect) |
View |
| 2025-02-04 Option Award |
2025-02-06 4:40 pm |
N/A 2035-02-04 |
Outlook Therapeutics Inc. | OTLK | Sukhtian Faisal Ghiath Director |
12,323 | $0 | 12,323 (Direct) |
View |
| 2025-01-17 Option Award |
2025-01-22 4:11 pm |
2024-03-18 2029-03-18 |
Outlook Therapeutics Inc. | OTLK | Sukhtian Ghiath M. GMS Ventures & Investments Director 10% Owner |
10,375,713 | $0 | 10,375,713 (Indirect) |
View |
| 2025-01-17 Exercise |
2025-01-22 4:11 pm |
2024-03-18 2029-03-18 |
Outlook Therapeutics Inc. | OTLK | Sukhtian Ghiath M. GMS Ventures & Investments Director 10% Owner |
3,458,571 | $0 | 10,375,713 (Indirect) |
View |
| 2024-10-01 Option Award |
2024-10-03 9:22 pm |
N/A 2034-10-01 |
Outlook Therapeutics Inc. | OTLK | Gangolli Julian S Director |
127,805 | $0 | 127,805 (Direct) |
View |
| 2024-10-01 Option Award |
2024-10-03 8:30 pm |
N/A 2034-10-01 |
Outlook Therapeutics Inc. | OTLK | Haller Julia A Director |
115,950 | $0 | 115,950 (Direct) |
View |
| 2024-10-01 Option Award |
2024-10-03 8:30 pm |
N/A 2034-10-01 |
Outlook Therapeutics Inc. | OTLK | Huang Andong Director |
91,129 | $0 | 91,129 (Direct) |
View |
| 2024-10-01 Option Award |
2024-10-03 8:30 pm |
N/A 2034-10-01 |
Outlook Therapeutics Inc. | OTLK | Auffarth Gerd Director |
98,211 | $0 | 98,211 (Direct) |
View |
| 2024-10-01 Option Award |
2024-10-03 8:30 pm |
N/A 2034-10-01 |
Outlook Therapeutics Inc. | OTLK | Haddadin Yezan Munther Director |
208,700 | $0 | 208,700 (Direct) |
View |
| 2024-10-01 Option Award |
2024-10-03 8:30 pm |
N/A 2034-10-01 |
Outlook Therapeutics Inc. | OTLK | Sukhtian Faisal Ghiath Director |
210,837 | $0 | 210,837 (Direct) |
View |
| 2024-10-01 Option Award |
2024-10-03 8:30 pm |
N/A 2034-10-01 |
Outlook Therapeutics Inc. | OTLK | HILZINGER KURT J Director |
180,459 | $0 | 180,459 (Direct) |
View |
| 2024-10-01 Option Award |
2024-10-03 8:30 pm |
N/A 2034-10-01 |
Outlook Therapeutics Inc. | OTLK | THURMAN RANDY H Director |
146,185 | $0 | 146,185 (Direct) |
View |
| 2024-03-20 Option Award |
2024-03-22 5:00 pm |
N/A 2034-03-20 |
Outlook Therapeutics Inc. | OTLK | TRENARY C RUSSELL III CEO AND PRESIDENT |
455,000 | $0 | 455,000 (Direct) |
View |
| 2024-03-20 Option Award |
2024-03-22 5:00 pm |
N/A 2034-03-20 |
Outlook Therapeutics Inc. | OTLK | Evanson Jeff CHIEF COMMERCIAL OFFICER |
25,000 | $0 | 25,000 (Direct) |
View |
| 2024-03-20 Option Award |
2024-03-22 5:00 pm |
N/A 2034-03-20 |
Outlook Therapeutics Inc. | OTLK | KENYON LAWRENCE A CHIEF FINANCIAL OFFICER |
12,500 | $0 | 12,500 (Direct) |
View |
| 2024-03-18 Option Award |
2024-03-20 5:20 pm |
2024-03-18 2029-03-18 |
Outlook Therapeutics Inc. | OTLK | Sukhtian Ghiath M. GMS Ventures & Investments Director 10% Owner |
5,764,285 | $0 | 9,266,645 (Indirect) |
View |
| 2024-03-07 Option Award |
2024-03-08 4:30 pm |
N/A 2034-03-07 |
Outlook Therapeutics Inc. | OTLK | Haller Julia A Director |
94,441 | $0 | 94,441 (Direct) |
View |
| 2024-03-07 Option Award |
2024-03-08 4:18 pm |
N/A 2034-03-07 |
Outlook Therapeutics Inc. | OTLK | Huang Andong Director |
94,441 | $0 | 94,441 (Direct) |
View |
| 2024-03-07 Option Award |
2024-03-08 4:14 pm |
N/A 2034-03-07 |
Outlook Therapeutics Inc. | OTLK | Auffarth Gerd Director |
94,441 | $0 | 94,441 (Direct) |
View |
| 2024-03-07 Option Award |
2024-03-08 4:13 pm |
N/A 2034-03-07 |
Outlook Therapeutics Inc. | OTLK | Gangolli Julian S Director |
94,441 | $0 | 94,441 (Direct) |
View |
| 2024-03-07 Option Award |
2024-03-08 4:11 pm |
N/A 2034-03-07 |
Outlook Therapeutics Inc. | OTLK | Haddadin Yezan Munther Director |
94,441 | $0 | 94,441 (Direct) |
View |
| 2024-03-07 Option Award |
2024-03-08 4:08 pm |
N/A 2034-03-07 |
Outlook Therapeutics Inc. | OTLK | Sukhtian Faisal Ghiath Director |
94,441 | $0 | 94,441 (Direct) |
View |
| 2024-03-07 Option Award |
2024-03-08 4:06 pm |
N/A 2034-03-07 |
Outlook Therapeutics Inc. | OTLK | HILZINGER KURT J Director |
94,441 | $0 | 94,441 (Direct) |
View |
| 2024-03-07 Option Award |
2024-03-08 4:04 pm |
N/A 2034-03-07 |
Outlook Therapeutics Inc. | OTLK | THURMAN RANDY H Director |
94,441 | $0 | 94,441 (Direct) |
View |
| 2023-10-04 Option Award |
2023-10-06 08:16 am |
N/A 2033-10-04 |
Outlook Therapeutics Inc. | OTLK | Gangolli Julian S Director |
370,282 | $0 | 370,282 (Direct) |
View |
| 2023-10-04 Option Award |
2023-10-05 5:15 pm |
N/A 2033-10-04 |
Outlook Therapeutics Inc. | OTLK | Haller Julia A Director |
210,225 | $0 | 210,225 (Direct) |
View |
| 2023-10-04 Option Award |
2023-10-05 5:14 pm |
N/A 2033-10-04 |
Outlook Therapeutics Inc. | OTLK | Huang Andong Director |
191,113 | $0 | 191,113 (Direct) |
View |
| 2023-10-04 Option Award |
2023-10-05 5:13 pm |
N/A 2033-10-04 |
Outlook Therapeutics Inc. | OTLK | Auffarth Gerd Director |
210,225 | $0 | 210,225 (Direct) |
View |
| 2023-10-04 Option Award |
2023-10-05 5:07 pm |
N/A 2033-10-04 |
Outlook Therapeutics Inc. | OTLK | Haddadin Yezan Munther Director |
358,337 | $0 | 358,337 (Direct) |
View |
| 2023-10-04 Option Award |
2023-10-05 5:06 pm |
N/A 2033-10-04 |
Outlook Therapeutics Inc. | OTLK | Sukhtian Faisal Ghiath Director |
372,671 | $0 | 372,671 (Direct) |
View |
| 2023-10-04 Option Award |
2023-10-05 5:05 pm |
N/A 2033-10-04 |
Outlook Therapeutics Inc. | OTLK | HILZINGER KURT J Director |
286,670 | $0 | 286,670 (Direct) |
View |
| 2023-04-17 Option Award |
2023-04-19 5:41 pm |
N/A 2033-04-17 |
Outlook Therapeutics Inc. | OTLK | Dagnon Terry Chief Operations Officer |
192,143 | $0 | 192,143 (Direct) |
View |
| 2023-04-17 Option Award |
2023-04-19 5:41 pm |
N/A 2033-04-17 |
Outlook Therapeutics Inc. | OTLK | Evanson Jeff Chief Commercial Officer |
192,143 | $0 | 192,143 (Direct) |
View |
| 2023-04-17 Option Award |
2023-04-19 5:40 pm |
N/A 2033-04-17 |
Outlook Therapeutics Inc. | OTLK | TRENARY C RUSSELL III CEO and President |
257,143 | $0 | 257,143 (Direct) |
View |
| 2023-03-29 Option Award |
2023-03-31 5:50 pm |
N/A 2033-03-29 |
Outlook Therapeutics Inc. | OTLK | Haddadin Yezan Munther Director |
41,065 | $0 | 41,065 (Direct) |
View |
| 2023-03-29 Option Award |
2023-03-31 5:49 pm |
N/A 2033-03-29 |
Outlook Therapeutics Inc. | OTLK | Haller Julia A Director |
41,065 | $0 | 41,065 (Direct) |
View |